Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy

Launched by CENTRE OSCAR LAMBRET · Mar 27, 2025

Keywords

ClinConnect Summary

The TABAC STOP ORL POUMON study is researching how to help patients with head and neck or lung cancer quit smoking for the long term. This trial is specifically looking at patients who are receiving treatment with radiotherapy or chemoradiotherapy, which are types of cancer treatments that use radiation and chemotherapy. The study aims to find out how many patients can stay smoke-free six months after their treatment and what factors help or hinder their ability to quit. Researchers will follow 100 patients for a year, checking in with them at 1, 6, and 12 months after their treatment ends.

To participate in this study, patients need to be 18 years or older and currently smoke or have smoked in the past. They must be undergoing treatment aimed at curing their cancer, rather than just easing symptoms. Patients who are receiving palliative care or are under guardianship are not eligible. Those who join the study will share their experiences and provide information that could help improve smoking cessation support for future patients. It's important to note that participation is voluntary, and patients can leave the study at any time if they choose.

Gender

ALL

Eligibility criteria

• Inclusion Criteria :
• • Patient aged 18 years or older
• • Diagnosed with head and neck cancer or lung cancer
• • Undergoing curative treatment with chemoradiotherapy, radiotherapy alone, or stereotactic radiotherapy
• • Current or former smoker
• • Patient covered by a social security scheme
• • Patient informed and having given consent for data collection
• • Patients with human papillomavirus (HPV) may also be included
• Exclusion Criteria :
• • Patient receiving palliative treatment
• • Patient under guardianship or curatorship
• Study Exit Criteria :
• • - Protocol-defined exit : After the 12-month consultation
• Early exit :
• • Withdrawal of consent for data collection
• • Death of the patient